Loading insider details...
Beta
Latest Form 4 (Aug 28, 2026): Exercise/Conversion of 2,000 URGN shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 28, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 2,000 | n/a |
| Jun 24, 2026 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| May 27, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 2,000 | n/a |
| Feb 27, 2026 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 2,000 | n/a |
| Jan 16, 2026 | Eledon Pharmaceuticals, Inc. (ELDN) | Exercise/Conversion | 3,430 | n/a |
| Dec 1, 2025 | UroGen Pharma Ltd. (URGN) | Exercise/Conversion | 2,000 | n/a |
| Aug 27, 2025 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| Jan 13, 2025 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 30,870 | n/a |
| Aug 8, 2024 | UroGen Pharma Ltd. (URGN) | Grant/Award | 10,000 | n/a |
| Oct 3, 2023 | Eledon Pharmaceuticals, Inc. (ELDN) | Grant/Award | 150,437 | $233.2K |